JNJ-28312141, a novel orally active colony-stimulating factor-1 receptor/FMS-related receptor tyrosine kinase-3 receptor tyrosine kinase inhibitor with potential utility in solid tumors, bone metastases, and acute myeloid leukemia
Manthey, C. L., Johnson, D. L., Illig, C. R., Tuman, R. W., Zhou, Z., Baker, J. F., Chaikin, M. A., Donatelli, R. R., Franks, C. F., Zeng, L., Crysler, C., Chen, Y., Yurkow, E. J., Boczon, L., MeegallVolume:
8
Language:
english
Journal:
Molecular Cancer Therapeutics
DOI:
10.1158/1535-7163.mct-09-0255
Date:
November, 2009
File:
PDF, 793 KB
english, 2009